RO7269162 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-19 in 4mo
ESTIMATED |
READOUT
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participant
Phase 2 · Alzheimer's Disease |
Hoffmann-La Roche | RO7269162 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|